MedTrace Logo

Natural History Study of Patients With Chronic Myelogenous Leukemia

NCT00429910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2017-01-02

No results posted yet for this study

Summary

RATIONALE: Gathering information about patients with chronic myelogenous leukemia may help doctors learn more about the disease and find better methods of treatment and on-going care.

PURPOSE: This natural history study is collecting health information and disease-related information over time from patients with newly diagnosed chronic myelogenous leukemia.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jerome Ritz, MD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00429910 on ClinicalTrials.gov